Antioxidant potential of specific estrogens on lipid peroxidation

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 4, 1993, Pages 1095-1097

  Subbiah, M T Ravi ^a   Kessel, Bruce ^a   Agrawal, Mukul ^a   Rajan, Raghunandan ^a   Abplanalp, William ^a   Rymaszewski, Zbigniew ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

EQUILENIN; EQUILIN; ESTRADIOL; ESTROGEN; ESTRONE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY RISK; ESTROGEN THERAPY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

CELL LINE; CHOLESTEROL; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUILIN; ESTRADIOL; ESTROGENS; ESTRONE; FATTY ACIDS; HUMAN; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MALONDIALDEHYDE; MONOCYTES; OXIDATION-REDUCTION;

EID: 0027442755     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.4.8408459     Document Type: Article

References (15)

1. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausalestrogentherapyandcardiovascular disease. N Engl J Med. 1991; 325:756-762.
2. Bush TL, Barrett-Connor E, Cowan LD et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-Up Study. Circulation. 1987; 75:1002-1009.
3. Gruchow HW, Anderson AJ, Barboriak JJ et al. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J. 1988; 115:954-963.
4. Heinecke JW. Free radical modification of low density lipoproteins; mechanism and biological consequences. Free Rad Biol Med. 1991; 3:65-73. 1991.
5. + + ions. Identification of major products and their effect. Biochem Biophys Res Comm. 1991; 176:431-440.
6. Maziere C, Auclair M, Ronveaux MC, Salmon S, Santus R and Maziere JC. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 1991; 89:175-182.
7. Yagi K and Komura S. Inhibitory effect of female hormones on lipid peroxidation. Biochem Intern. 1986; 13:1051-1055.
8. Huber LA, Scheffler E, Poll T, Ziegler R and Oresel HA. 17β-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Rad Res Comm. 1990; 8:167-175.
9. Jansson G. Oestrogen-induced enhancment of myeloperoxidase activity in human PMN leukocytes; a possible cause of oxidative stress in inflamatory cells. Free Rad Res Comm. 1991; 14:195-208.
10. Mukai K, Daifuku K, Yokoyama S and Nakano M. Stopped flow investigation of antioxidant effects of estrogen. Biochim Biophys Acta. 1990; 1035:348-352.
11. Bhavnani BR. The saga of ring B unsaturated equine estrogens. Endocrin Rev. 1988; 9:396-416.
12. Arshad MAQ, Bhadra S, Cohen RM and Subbiah MTR. Plasma lipoprotein peroxidation potential. A test to evaluate individual susceptibility to peroxidation. Clin Chem. 1991; 37:1756-1758.
13. Satoh K. Serum lipid peroxides in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta. 1987; 90:3743.
14. Buckley MM, Goa KL, Price AH and Brogden RN. Probucol: A reappraisal of its pharmacological properties and therapeutic use in familial hypercholesterolemia. Drugs. 1989; 37:761-800.
15. Yamamoto A, Matsuzawa Y, Yokoyma S, Funahashi T, Yamamura T and Kichino B. Effect of probucol on xanthoma regression in familial hypercholesterolemia. Am J Cardiol. 1986; 57:29H-35H.